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Abstract 
Background: Little is known about the epidemiology of Toxoplasma gondii and Neospora caninum infections in 
alpacas (Vicugna pacos) and llamas (Lama glama) outside South America. The study aimed to estimate the seropreva‑
lence of T. gondii and N. caninum infections in South American camelids (SAC) in Switzerland, to optimize serological 
tests for SAC and to identify risk factors, which may favour infection.
Methods: A total of 571 sera from 132 Swiss farms (374 alpacas and 197 llamas, mean 4.3 animals/farm) were 
obtained. Four commercial enzyme‑linked immunosorbent assays (ELISA) for detecting antibodies against T. gondii (ID 
 Screen® Toxoplasmosis Indirect (TOXO‑MS)) or N. caninum (i.e. ID  Screen® Neospora caninum Indirect Multi‑species 
(NCS‑MS); ID  Screen® Neospora caninum Competition (NCC) and ID  Screen® Neospora caninum Indirect (NCS)) were 
first assessed for their use on SAC comparing their results with those in immunoblot, and optimizing cut‑offs. Sub‑
sequently, two kits (TOXO‑MS and NCS‑MS) were selected for seroprevalence estimation. Additionally, a risk factor 
analysis for infection was performed on 41 farms, which agreed to participate in a web‑based survey.
Results: Three kits (TOXO‑MS, NCS‑MS and NCC) showed almost perfect agreement (kappa > 0.901) with immunoblot 
results when the cut‑offs were optimized, and one kit (NCS) proved not to be useful for detecting N. caninum seroposi‑
tive SAC. By TOXO‑MS ELISA, 82.3% (308/374) of the alpacas and 84.8% (167/197) of the llamas were seropositive for T. 
gondii, and 131/132 (99.2%) farms had seropositive animals. By NCS‑MS ELISA, 3.5% (13/374) of the alpacas and 2.5% 
(5/197) of the llamas evidenced antibodies against N. caninum, and 9.1% (12/132) of the farms had seropositive animals. 
The variables “age” and “female sex” were identified as risk factors for T. gondii infection and “absence of cats in the farm 
during the last two years” as a protective factor. No risk or protective factors for N. caninum infection could be identified.
Conclusions: This nationwide cross‑sectional study demonstrated for the first time the presence of antibodies 
against T. gondii and N. caninum in the Swiss SAC population, highlighting a high seroprevalence for T. gondii, the 
presence of cats as a risk factor and suggesting that SAC meat might represent an additional infection source for 
humans.
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Background
Toxoplasma gondii and Neospora caninum (Apicom-
plexa: Sarcocystidae) are worldwide distributed cyst-
forming coccidian parasites, which represent important 
causes of abortion and congenital infections in rumi-
nants [1, 2]. Both parasites have heteroxenous life-
cycles, with sexual development and oocyst production 
in the intestine of the definitive hosts and asexual 
development in extraintestinal tissues of the interme-
diate hosts. Only felids are natural definitive hosts for 
T. gondii [1] and only domestic dogs, dingoes, coyotes 
and wolves have been identified as definitive hosts for 
N. caninum so far [2]. Whereas cattle and other rumi-
nants are the main intermediate hosts of N. caninum, 
all warm-blooded species (birds and mammals, includ-
ing humans) are potential intermediate hosts of T. gon-
dii [1, 2]. Ruminants may become infected with these 
protozoan parasites either horizontally through inges-
tion of oocysts shed by the definitive hosts with the 
faeces, or vertically by transplacental parasite transmis-
sion from the dam to the foetus [1, 2]. Carnivorous and 
omnivorous animals can also become infected through 
consumption of tissues from infected hosts containing 
cyst stages [3].
Infections with both parasites were described in 
numerous domestic and wild animal species, with varia-
ble clinical manifestations. Toxoplasma gondii infections 
are frequently asymptomatic but they may be associated 
with fatal disease in some hosts, including humans. Cer-
tain animal species such as Pallas’ cats [4], meerkats [5], 
Australian marsupials [6, 7] and New World primates 
[8] are highly susceptible to clinical toxoplasmosis and 
can develop fatal generalized infections. Additionally, T. 
gondii is considered one of the most important causes of 
abortion in small ruminants [9, 10], but noteworthy, it 
has no epidemiological significance as an abortifacient 
agent in cattle [1]. In humans, toxoplasmosis is consid-
ered one of the most common zoonoses worldwide and 
can cause serious illness especially after congenital infec-
tions or in immunosuppressed patients [1, 11]. Primary 
T. gondii infections in women during pregnancy may be 
associated with prenatal infection and severe damage to 
the foetus (including hydrocephalus, intracerebral calci-
fications, mental retardation, chorioretinitis and death). 
In immunosuppressed patients, chronic infections can 
be reactivated leading to encephalitis or generalized 
toxoplasmosis [1, 11]. In recent years, T. gondii infec-
tions were also regarded as common cause of ocular dis-
ease in postnatal infections both in immunosuppressed 
and immunocompetent individuals [12]. In contrast to 
T. gondii, N. caninum has no zoonotic character but it is 
regarded as one of the major causes of abortion in cattle 
worldwide [2]; besides, it can also cause reproductive 
failure (i.e. abortion, stillbirths and perinatal mortality) in 
other ruminant species such as goats [13–15], sheep [16] 
and deer [17]. Furthermore, it represents an important 
cause of neuromuscular disease and death in dogs [2, 13, 
17].
Little is known about the meaning of toxoplasmosis 
and neosporosis in South American camelids (SAC) out-
side South America. Only few studies worldwide showed 
that T. gondii and N. caninum infections may occur in 
SAC (Tables  1 and 2), and that these infections may be 
occasionally associated with abortions [18–20] as well as 
with fatal generalized infection [21].
South American camelids are of great economic 
importance in the Andean Region of South America, 
where they are mainly bred for meat and fibre and repro-
ductive problems may impair their breeding, causing 
significant economic losses [18]. Moreover, meat from 
infected SAC may be a potential infection source of T. 
gondii for humans, as it is often consumed undercooked. 
In Europe, the popularity and interest for SAC has shown 
a notable increase in the last years. Llamas (Lama glama) 
and alpacas (Vicugna pacos) are bred not only for fibre 
and meat production, but also for other purposes such 
as landscape maintenance, trekking, animal-assisted 
activities and therapy and also as companion animals 
[22, 23]. Llamas have also been used as guard animals 
in sheep herds against predation by lynxes in Switzer-
land [22] and coyotes in the USA [24] due to their nat-
ural aggressive behaviour against these animals. While 
at the beginning of year 2000 a total population of only 
1622 SAC (623 alpacas and 999 llamas) and 257 breed-
ers were registered in Switzerland [22], current records 
from the Swiss Federal Office for Statistics, revealed a 
total of 6739 SAC (3759 alpacas and 2980 llamas) in 2018, 
and a further significant increase (+1.3%) in the alpaca 
population was estimated for 2019 [25]. This new situa-
tion represents a challenge for many veterinary practi-
tioners in Europe, which are not familiar with the special 
management and sanitary requirements of these animal 
species. Although SAC share some viral, bacterial and 
parasitic agents with domestic and wild ruminants, the 
clinical significance and management of the infections 
might be different [22, 26]. For example, while Dicrocoe-
lium spp. infections are generally subclinical in cattle and 
small ruminants, they can cause severe liver lesions and 
fatal disease in SAC [26–28]. Moreover, SAC-specific 
nematodes (e.g. Graphinema auchenia, Spiculopteragia 
peruviana, Nematodirus lamae, Lamanema chavezi and 
Camelostrongylus spp.) are not common in Europe, and 
llamas and alpacas are frequently infected with nema-
todes from other ruminant species, but the strategies 
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used for controlling parasites in cattle and small rumi-
nants cannot be always directly extrapolated to SAC due 
to differences in pharmacokinetics, safety and efficacy for 
most antiparasitic drugs [26]. Therefore, a better under-
standing of the epidemiology and management of infec-
tious and parasitic diseases of SAC in Europe is required.
The aims of this study were (i) to estimate the occur-
rence, distribution and importance of T. gondii and N. 
caninum infections in SAC in Switzerland, (ii) to opti-
mize serological tests for this purpose, and (iii) to identify 
risk factors, which may favour T. gondii and N. caninum 
infections in these animal species.
Methods
Field samples from South American camelids and farm 
data
In order to estimate the nationwide seroprevalence of T. 
gondii and N. caninum infections in alpacas and llamas 
in Switzerland, a cross-sectional study including all 26 
Swiss cantons was conducted. Registered SAC breeders 
were contacted by phone and invited to participate in 
the study. Each participating farm was visited, and blood 
samples from randomly selected animals (mean 4.3 sam-
pled animals/farm) were obtained from the vena jugu-
laris. Subsequently, serum was extracted and conserved 
Table 1 Seroprevalence of T. gondii antibodies in South American camelids
a S/P (%) calculated according to the formula: S/P %= (OD sample/OD positive control) × 100, OD optical density
Abbreviations: cELISA, competitive-inhibition enzyme-linked immunosorbent assay; IFAT, indirect fluorescent antibody test; FITC, fluorescein isothiocyanate conjugate; 
IHA, indirect hemagglutination; MAT, modified agglutination test
Country (Region) SAC species Test (commercial provider) Cut‑off No. positive/
No. 
examined
% Positive Reference
Peru (Lampa, Puno) Alpaca IHA (Toxotest, Wiener Lab.) 1:16 89/200 44.5 [48]
Llama 38/136 27.9
Peru (Canchis, Cusco) Alpaca IFAT 1:50 97/272 35.7 [49]
Peru (Peruvian Andes, Central and 
South Sierra)
Llama IFAT
Conjugate: anti‑llama IgG‑FITC (VMRD) 
+ confirmation of positive results by 
Western blot
1:50 19/43 44.2 [69]
Vicuna 11/200 5.5
Peru (Puno, South‑Eastern Peru) Alpaca Immunoblot T. gondii 20/675 3.0 [30]
Llama 7/81 8.6
Vicuna 3/114 2.6
Peru (Central Sierra) Alpaca IHA (Toxotest, Wiener Lab.). 1:16 42/200 21.0 [50]
Peru (Central Sierra) Alpaca IFAT
Conjugate: anti‑llama IgG‑FITC (VMRD)
1:200 22/258 8.5 [70]
Peru (Melgar, Puno) Llama IFAT 1:200 16/107 14.9 [71]
Peru (Central and South Peruvian 
Andes)
Alpaca IFAT
Conjugate: anti‑llama IgG FITC (VMRD)
1:200 706/2874 24.6 [57]
Llama 460/1845 24.9
Argentina (Jujuy) Llama IFAT
Conjugate: anti bovine IgG FITC 
(Sigma‑Aldrich)
1:50 44/308 14.3 [37]
Chile Alpaca IHA (in‑house) 1:16 32/447 7.2 [38]
Chile Alpaca MAT 1:25 15/127 11.8 [39]
Llama 49/113 43.3
USA (Northwest: Oregon, Washington 
State and Idaho)
Llama MAT 1:25 95/283 33.5 [41]
USA Virginia Alpaca MAT 1:25 6/16 37.5 [40]
Germany (Hesse) Alpaca Immunoblot T. gondii 4/12 33.3 [30]
Llama 10/20 50.0
Czech Republic Alpaca ELISA (ID Screen Toxoplasmosis indirect 
multispecies ID.vet)
S/P (%) ≥ 50%a 1/1 100 [42]
Llama 7/8 88.0
Alpaca IFAT
Conjugate: anti‑llama IgG FITC (VMRD)
1:50 0/1 0
Llama 4/8 50.0
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at − 20 °C until analysis. At sampling, data on the farm 
(owner, register No. and location) and sampled animals 
(species [alpaca/llama], age and sex) were collected.
A total of 571 serum samples (i.e. 374 alpacas and 197 
llamas) from 132 farms distributed along all 26 Swiss 
cantons was obtained (Fig.  1). The collected samples 
represented 8.6% of the total SAC population (n = 6619) 
and 10.2% and 6.7% of the total alpaca and llama popula-
tions (n = 3666 and 2953, respectively) in Switzerland at 
the beginning of sampling, respectively [29].
In order to assess putative risk factors for exposure, a 
standardized web-based questionnaire was prepared in 
Table 2 Seroprevalence of N. caninum antibodies in South American camelids
cELISA: competitive-inhibition enzyme-linked immunosorbent assay, IFAT: indirect fluorescent antibody test; a %I (% inhibition) calculated according the formula: %I 
= 100 − (OD sample × 100/mean OD negative control), OD optical density, S/P (%) calculated according to the formula: S/P = (OD sample/OD positive control) × 100; 
FITC: fluorescein isothiocyanate conjugate
Country
Region
SAC species Test (commercial provider) Cut‑off No. positives/
No. examined
% Positives Reference
Peru
Highlands, Central and Southern Peru
Alpaca IFAT
conjugate: anti‑llama IgG FITC (VMRD)
1:50 39/92 42.4 [58]
Llama 1:50 39/212 18.4
Peru
Highlands, different regions
Alpaca IFAT
conjugate: anti‑llama IgG–FITC (VMRD) 
+ confirmation of positive results by 
Westernblot
1:50 14/78 17.9 [59]
Llama 17/73 23.3
Peru
Puno, South‑Eastern Peru
Alpaca Immunoblot N. caninum 17/675 2.5 [30]
Llama 1/81 1.2
Vicuna 0/114 0
Peru
Yauli, Central Sierra
Alpaca IFAT
conjugate: anti‑llama IgG FITC (VMRD)
1:100 5/175 2.9 [72]
Peru
Central and South Peruvian Andes
Alpaca IFAT
conjugate: anti‑llama IgG FITC (VMRD)
1:100 425/2874 14.8 [57]
Llama 153/1845 8.3
Peru
Arequipa, South Peruvian Andes
Vicuna ELISA, Chekit Neospora – cELISA (IDEXX) 
+ confirmation of positive results by 
Westernblot
2/207 1.0 [73]
Alpaca 2/571 0.3
Llama 0/43 0
Peru
Huancavelica
Llama IFAT
conjugate: anti‑llama IgG FITC (VMRD)
1:100 12/98 12.2 [56]
Peru
Huancavelica
Alpaca IFAT 1:100 47/288 16.3 [55]
Argentina
Jujuy
Llama IFAT
conjugate: anti bovine IgG FITC (Sigma)
1:50 3/308 1.0 [37]
Australia
South
Alpaca ELISA, N. caninum Antibody Test Kit ELISA 
(IDEXX) + Protein G conjugate (Zymed 
Recombinant Protein G HRP Conjugate, 
Invitrogen)
0/182 0 [53]
Australia
New South Wales and Victoria
Alpaca ELISA, N. caninum Antibody Test Kit – cELISA 
(VMRD)
%I ≥ 30%a 3/100 3.0 [24]
Germany
Hesse
Alpaca Immunoblot N. caninum 0/12 0 [30]
Llama 0/20 0
Czech Republic Alpaca ELISA, N. caninum Antibody Test Kit – cELISA 
(VMRD)
%I ≥ 30%a 0/1 0 [42]
Llama 1/8 12.5
Alpaca IFAT
conjugate: anti‑llama IgG FITC (VMRD)
1:50 0/1 0
Llama 1/8 12.5
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three Swiss national languages (i.e. German, French and 
Italian) and subsequently sent to the participating farms 
via e-mail. The questionnaire contained general ques-
tions on the farm, animals (i.e. SAC species, breed, num-
ber of SAC in the farm, origin), management (i.e. type 
of water supply, type of feeding, feed storage, presence 
and number of cats and dogs (and especially of kittens 
and puppies < 6 months-old) in the farm during the last 
two years, access of cats/dogs to the stables and pasture, 
problems with rodents, presence of other animal species) 
and occurrence of abortions. Answering of the question-
naire was voluntary for all participants. All collected data, 
as well as the subsequent evaluations were processed 
confidentially.
Control sera
In all serological tests, known N. caninum or T. gondii 
positive and negative control sera were included in addi-
tion to those provided with the kits.
For the evaluation of commercial N. caninum ELISAs 
and in-house N. caninum immunoblot, serial sera from 
two 1-year-old llamas, which had been intravenously 
(iv) inoculated either with 4.8 × 10E6 cell culture-
derived N. caninum tachyzoites (Llama 1) or with 5 × 
10E4 Vero cells (Llama 2) on day 0 of the experiment 
were used as positive and negative controls, respectively 
[30]. Serum samples from both animals were collected 
at 12 time points between days 0 and 52 after inocula-
tion. While Llama 1 seroconverted against N. caninum, 
Llama 2 remained seronegative throughout the observa-
tion period [30]. Serum samples of both llamas obtained 
on day 52 post-inoculation were used as internal positive 
and negative controls in all test runs, in addition to the 
controls provided by the manufacturer.
For the evaluation of a commercial T. gondii ELISA 
and in-house T. gondii immunoblot, control sera from 
a naturally infected llama (Llama 2) (this llama, used as 
negative control in the experimental inoculation with N. 
caninum was seropositive for T. gondii at all samplings), 
five naturally infected alpacas (Alpaca 1-5) and three 
seronegative alpacas (Alpaca 6-8), previously tested at 
the Friedrich-Loeffler-Institut (FLI), Germany, by immu-
noblot were used. In all test runs positive (Llama 2) and 
negative (Alpaca 8) internal control sera were included 
in addition to the controls provided by the manufacturer. 
Fig. 1 Map of Switzerland showing the distribution of South American camelid (SAC) breeding farms (n = 132) sampled in the study (all dots) and 
the farms in which N. caninum seropositive SAC were detected (red dots)
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Additionally, in N. caninum tests, serum from a calf, 
experimentally inoculated with N. caninum tachyzoites 
was used [31].
Serological tests
Since no validated serological tests for antibody detection 
against T. gondii or N. caninum in SAC were available, in 
the first phase of the study commercial ELISA kits were 
evaluated for their use in these animal species comparing 
their results with those of immunoblot tests.
ELISA
In a first step, two commercially available ELISA kits: ID 
Screen® Toxoplasmosis Indirect (TOXO-MS; for dogs, 
cats, goats, sheep, cattle and pigs; ID.vet, Grabels, France) 
and ID Screen® Neospora caninum Indirect Multi-spe-
cies (NCS-MS; for dogs, goats, sheep and cattle; ID.vet) 
were used for screening according to the manufacturerʼs 
instructions. In both kits, multi-species conjugates were 
used as secondary antibodies.
For each serum, a sample-to-positive ratio (S/P ratio) 
was calculated based on the optical density (OD) of the 
sample and the positive and negative controls of the kit 
according to the formula S/P% = (OD sample − OD neg-
ative control/ OD positive control − OD negative con-
trol) × 100. According to the manufacturer, animals with 
S/P% ≤ 40% are considered negative, inconclusive if 40% 
< S/P% > 50% and positive if S/P% ≥ 50%. Since these kits 
are not validated for SAC, the ELISA cut-offs were later 
re-adjusted based on immunoblot results.
In order to assess if the results obtained with NCS-MS 
ELISA were comparable with those from other kits, in a 
second step, all sera tested for antibodies against N. cani-
num by both NCS-MS ELISA and N. caninum immu-
noblot were re-tested by two additional ELISA kits: (i) 
ID Screen® Neospora caninum Indirect (NCS; indirect 
ELISA for detection of antibodies against N. caninum 
in serum, plasma or milk from cattle, sheep or goats; 
ID.vet), which uses an anti-ruminant conjugate; and (ii) 
ID Screen® Neospora caninum Competition (NCC; com-
petitive ELISA for detection of antibodies against N. cani-
num in serum or plasma from cattle, sheep, goats, dogs or 
other susceptible species; ID.vet). The cut-offs indicated 
by the manufacturer for NCS ELISA were the same ones 
as for NCS-MS ELISA. In the Competition ELISA, for 
each sample the competition percentage (S/N%) was cal-
culated according to the formula: S/N% = (OD sample/
OD negative control) × 100. The recommended cut-offs 
by the manufacturer were: S/N% ≤ 50%: positive, doubt-
ful if 50% < S/N% ≤ 60% and negative if S/N% > 60%. The 
Competition ELISA was performed with the overnight 
incubation protocol, as described by the manufacturer.
Immunoblot
At the Institute of Parasitology, Vetsuisse Faculty Bern 
(IPB), in-house T. gondii tachyzoite surface antigen 
TgSAG1 (P30)-based and N. caninum tachyzoite-based 
immunoblots were performed to confirm ELISA results 
or to optimize the cut-offs of the commercial kits.
Pellets containing either 3 µg of native affinity-purified 
T. gondii TgSAG1 antigen (TOXO P30 B-10 Antigen, 
SR2B: Société de Recherche et de Réalisations Biotech-
nologiques, Avrillé, France) or 2.6 × 10E7 N. caninum 
tachyzoites were resuspended in 400 μl sample buffer [32], 
incubated for 5 min at 95 °C and 1000 rpm in a Thermo-
mixer compact (Eppendorf), and electrophoresed in two 
precast polyacrylamide gels  (CriterionTM TGX Stain-
FreeTM 4–20% precast gels for PAGE, Bio-Rad, Hercules, 
CA, USA) under non-reducing conditions along with a 
pre-stained protein standard (Precision Plus  ProteinTM 
Dual Extra Standards, Bio-Rad). Subsequently, the anti-
gens were electrophoretically transferred to nitrocellu-
lose membranes (Trans-Blot  TurboTM, Bio-Rad), cut into 
stripes and blocked for 30 min with blocking solution 
(PBS with 0.05% (v/v) Tween 20 (Sigma, Munich, Ger-
many) and 2% (v/v) fish gelatine (Serva Electrophoresis 
GmbH, Heidelberg, Germany)). Selected serum samples 
(according to ELISA results) were tested at 1:100 dilution 
in blocking solution and incubated at room temperature 
for 60 min. Afterwards, the stripes were washed 5 times 
during 5 min with 0.05% Tween 20-PBS solution. For 
detection of specific antibodies against T. gondii-SAG1 
antigen or against N. caninum, the stripes were incubated 
with a rabbit anti-llama IgG (H + L) secondary antibody, 
HRP (Invitrogen, Thermo Fisher Scientific, Waltham, 
MA, USA) at 1:600 dilution in 0.05% Tween 20-PBS at 
room temperature for 60 min. Washing was performed 
as indicated above and followed by a 15–20 min incuba-
tion step with substrate solution (40 µl  H2O2 (30% (v/v) 
and 30 mg 4-chloro-1-naphthol (Sigma-Aldrich) in 40 ml 
PBS, 20% (v/v) methanol). The reaction was stopped by 
addition of distilled water. For T. gondii, a serum reaction 
against the immunodominant antigen TgSAG1 visible as 
a sole band of a relative molecular mass of 30 kDa was 
recorded as positive. For N. caninum, a serum was consid-
ered positive when reaction against at least two out of five 
N. caninum relevant immunodominant antigens (i.e. 17, 
29, 30, 33 and 37 kDa) were observed [30, 32]. If only one 
band was visible, the sample was considered inconclusive.
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ROC‑analysis and optimization of ELISA cut‑offs for SAC
The R software, version 3.5.3 [33] and the R package opti-
mal.cutpoints were used to define optimal cut-offs for the 
commercial ELISA kits to detect antibodies against T. 
gondii (TOXO-MS) and N. caninum (NCS-MS and NCC) 
in SAC. For this, receiver operating characteristics (ROC) 
curve analysis was used, and relative to the immunoblot 
results the area under the ROC curve (AUC), diagnostic 
sensitivity, specificity, and positive and negative predic-
tive values including 95% confidence intervals (95% CI) 
were determined. According to an arbitrary guideline, the 
area under the curve (AUC) was considered: non-inform-
ative (AUC = 0.5); low accurate (0.5 < AUC ≤ 0.7); mod-
erately accurate (0.7 < AUC ≤ 0.9); highly accurate (0.9 < 
AUC < 1); or perfect (AUC = 1) [34].
To evaluate the agreement among different tests con-
sidering the ELISA cut-offs suggested by the manufac-
turer and the optimized cut-offs, an inter-rater agreement 
(kappa) was calculated [35] and kappa values (κ) were 
considered as follows: slight agreement (ĸ = 0–0.20); 
fair agreement (ĸ = 0.21–0.40); moderate agreement (ĸ 
= 0.41–0.60); substantial agreement (ĸ = 0.61–0.80); or 
almost perfect agreement (ĸ = 0.81–1.00) [36].
Risk factor analysis
A risk factor analysis for T. gondii and N. caninum sero-
positivity was performed based on the information col-
lected with the web-based questionnaire.
First, univariate models were performed consider-
ing the farm status (“seropositive” or “seronegative”) 
as dependent variables and the potential risk factors 
included in the questionnaire as independent variables. 
One farm was considered “seropositive” for T. gondii 
or N. caninum when at least one of the tested animals 
in the farm gave a positive serological result for these 
parasites. All risk factors were tested as categorical vari-
ables with the Pearsonʼs Chi-square test and the Likeli-
hood Ratio. The null hypothesis (H0) aimed to prove the 
independence between the infection status and the cor-
responding risk factors (categorical variables).
Secondly, bivariable-multilevel-modelling (general-
ized linear mixed modelling fit by maximum likelihood 
(Laplace approximation)) was performed using R (http://
www.R-proje ct.org) version 3.3.5, by applying the pack-
age lme4. Because individual animals clustered in farms, 
“farm” was included as a random effect variable. Because 
in T. gondii seropositivity increased with age, “age” (in 
months) of individual animals had to be regarded as an 
important risk or effect-modifying explanatory variable. 
Thus, data on age of the animals were included into each 
of the bivariable models calculated. Animals, for which 
no birth date was available were excluded from the analy-
sis. The Akaike information criterion (AIC) was used to 
characterize the relative model quality. The serological 
status (“seropositive” or “seronegative”) for T. gondii and 
N. caninum infections that were considered in the anal-
yses were those obtained by TOXO-MS and NCS-MS 
ELISA, respectively, when the optimized cut-offs were 
used.
Results
ID Screen® Toxoplasmosis indirect ELISA (TOXO‑MS)
Considering the thresholds suggested by the kit’s manu-
facturer, 468/571, 4/571 and 99/571 of the tested animals 
showed a positive, inconclusive and negative result for T. 
gondii, respectively.
Llama 1, experimentally inoculated with N. cani-
num remained seronegative for T. gondii throughout 
the experimental period (ELISA S/P values between 
9.34–17.76%). Llama 2, experimentally inoculated with 
Vero cells and used as a negative control for N. caninum, 
always showed ELISA S/P values above 100% (106.41–
129.12%) for T. gondii and was therefore considered 
as naturally infected with this parasite. All five known 
naturally infected alpacas (Alpaca 1-5) used as positive 
controls also gave positive results in the T. gondii ELISA 
(S/P 122.81–207.11%). The two negative control alpacas 
Table 3 Results of receiver operating chraracteristics (ROC) analysis
Notes: Relative accuracies of commercial ELISA kits used for detection of antibodies against Toxoplasma gondii (i.e. ID Screen® Toxoplasmosis Indirect ELISA) and 
N. caninum (i.e. ID Screen® Neospora caninum Indirect Multi-species ELISA and ID Screen® Neospora caninum Competition ELISA) in South American camelids, in 
relation to N. caninum and T. gondii immunoblots
Abbreviations: TOXO-MS, ID Screen® Toxoplasmosis Indirect; NCS-MS, ID Screen® Neospora caninum Indirect Multi-species ELISA; NCC, ID Screen® Neospora caninum 
Competition; S/P%, sample-to-positive ratio; S/N%, competition percentage; AUC, area under the ROC curve; CI, confidence interval; TP, true positives; FP, false 
positives; TN, true negatives; FN, false negatives; PPV, positive predictive value; NPV, negative predictive value; NaN, upper limit of the confidence interval could not 
be computed
ELISA Kit Optimized ELISA cut‑off AUC 
(95% CI)
% Relative 
sensitivity (95% 
CI)
% Relative specificity (95% CI) PPV % (95% CI) NPV % (95% CI)
TOXO‑MS ≥ 36.2 S/P% 0.97 (0.94–1.00) 94.5 (87.6–98.2) 97.9 (92.6–99.7) 97.7 (92.0–99.3) 94.9 (88.5–99.4)
NCS‑MS ≥ 34.9 S/P% 0.96 (0.91–1.01) 89.3 (71.8–97.7) 100.0 (95.4–NaN) 100 (86.9–100) 96.3 (88.8–NaN)
NCC ≤ 78.6 S/N% 0.97 (0.92–1.01) 92.9 (76.5–99.1) 97.4 (91.0–99.7) 92.9 (77.7–99.1) 97.4 (90.5–99.7)
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(Alpaca 6-8) tested also negative in the commercial 
ELISA with values well below the cut-off suggested by the 
manufacturer (S/P 4.1%, 3.05% and 10.08%, respectively). 
When the cut-off was re-adjusted based on ROC analysis 
considering the immunoblot results (Table 3; i.e. cut-off 
= S/P 36.2%, relative sensitivity = 94.5%, relative speci-
ficity = 97.9%), the general seroprevalence at the ani-
mal level was 83.2% (475/571, i.e. 82.3% (308/374) of the 
alpacas and 84.8% (167/197) of the llamas were seroposi-
tive for T. gondii) and the seroprevalence at the farm level 
was 99.2% (131/132). Only in one of the 132 participat-
ing farms all tested animals (4/4) were seronegative for T. 
gondii.
Toxoplasma gondii immunoblot
All control animals (n = 9) and selected field serum sam-
ples (n = 177) based on the ELISA results using the man-
ufacturer’s cut-offs were tested by immunoblot, i.e. all 
negative samples (n = 97; S/P 1.70–39.13%), all samples 
with inconclusive results (n = 4; S/P 42.30–49.93%) and 
all positive samples with S/P values of 50.83–101.07% 
(n = 26), as well as five groups of five samples each, 
randomly selected within arbitrarily defined intervals 
(i.e. group 1: S/P 120.14–125.07%; group 2: S/P 149.93–
152.30%; group 3: S/P 170.74–172.33 %; group 4: S/P 
190.29–191.09%; group 5: S/P 220.00–221.70%); and 
the 25 serum samples with the highest S/P values  (S/P 
247.04–284.23%) (Fig. 2).
The T. gondii ELISA kit showed almost perfect 
agreement with immunoblot results (considering the 
manufacturer’s cut-off, weighted k = 0.887; consider-
ing the optimized cut-off, k = 0.925) (Table  4). All but 
two (86/88) of the selected animals with positive ELISA 
results and all four samples with inconclusive results 
yielded positive results in immunoblot. Eight out of 102 
serum samples that were first considered negative in 
ELISA (S/P < 40%) showed a positive result in the immu-
noblot. The T. gondii naturally infected llama (Llama 2) 
and all five naturally infected alpacas (Alpaca 1-5) showed 
immunoblot positive reactions, and the negative control 
alpacas (Alpaca 6-8) were confirmed as seronegative.
ID Screen® Neospora caninum indirect multi‑species ELISA 
(NCS‑MS)
Considering the cut-offs proposed by the manufacturer 
for other animal species, 14/571, 3/571 and 554/571 out 
of the tested SAC field samples yielded a positive, incon-
clusive and negative result for N. caninum, respectively. 
Considering these cut-offs, the llama experimentally 
infected with N. caninum (Llama 1) showed inconclusive 
ELISA values between 19–23 dpi (S/P 43.45–49.66%) and 
positive values (S/P ≥ 51.45%) from 26 dpi until the end 
of the observation period (52 dpi). The negative control 
animal (Llama 2) showed S/P values below the cut-off 
(1.89–4.82%) at all samplings (Fig. 3).
In order to adapt the kit for testing SAC, the ELISA 
cut-off was recalculated by a ROC-analysis based on the 
immunoblot results (Table 3). With an optimized cut-off 
(i.e. cut-off = S/P 34.9%, relative sensitivity = 89.3%, rela-
tive specificity = 100%), 3.15% (18/571) of the sampled 
Fig. 2 Immunoblot results for antibodies against T. gondii in Swiss South American camelids (SAC). Abbreviations: M, molecular marker; Neg, 
seronegative Swiss SAC field samples; Pos, seropositive Swiss SAC field samples; PC, positive control (Llama); NC, negative control (Llama); >, 30 kDa 
band corresponding to SAG‑1 T. gondii tachyzoite surface antigen. Samples recognizing the 30 kDa antigenic band were considered positive
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Table 4 Inter‑rater agreement (Kappa value) between ELISA kits for detection of antibodies against T. gondii (ID Screen® 
Toxoplasmosis Indirect) or N. caninum (ID Screen® Neospora caninum indirect multi‑species and ID Screen® Neospora caninum 
Competition) and immunoblot, and between ELISA kits (ID Screen® Neospora caninum Indirect Multi‑species and ID Screen® 
Neospora caninum Competition)
TOXO-MS: ID Screen® Toxoplasmosis Indirect; NCS-MS: ID Screen® Neospora caninum Indirect Multi-species ELISA; NCC: ID Screen® Neospora caninum Competition; 
SE: Standard Error; CI : Confidence Interval
TOXO‑MS (manufacturer’s cut‑offs) TOXO‑MS (optimized cut‑off )
Positive Doubtful Negative Total Positive Doubtful Negative Total
T. gondii immunoblot Positive 80 3 8 91 86 0 5 91
Doubtful 0 0 0 0 0 0 0 0
Negative 1 0 94 95 2 0 93 95
Total 81 3 102 186 88 0 98 186
Kappa (κ) 0.873 0.925
SE of κ 0.035 0.028
95% CI 0.804–0.941 0.870–0.979
Weighted κ 0.887 0.925
NCS‑MS (manufacturer’s cut‑offs) NCS‑MS (optimized cut‑off )
Positive Doubtful Negative Total Positive Doubtful Negative Total
N. caninum immunoblot Positive 19 5 4 28 25 0 3 28
Doubtful 0 0 2 2 0 0 2 2
Negative 0 0 76 76 0 0 76 76
Total 19 5 82 106 25 0 81 106
Kappa (κ) 0.739 0.879
SE of κ 0.066 0.052
95% CI 0.610–0.868 0.777–0.981
Weighted κ 0.806 0.901
NCC (manufacturer’s cut‑offs) NCC (optimized cut‑off )
Positive Doubtful Negative Total Positive Doubtful Negative Total
N. caninum immunoblot Positive 21 5 2 28 26 0 2 28
Doubtful 1 1 0 2 2 0 0 2
Negative 0 0 76 76 1 0 75 76
Total 22 6 78 106 29 0 77 106
Kappa (κ) 0.819 0.884
SE of κ 0.055 0.049
95% CI 0.710–0.927 0.788–0.980
Weighted κ 0.876 0.905
A NCC (manufacturer’s cut‑offs) B NCC (optimized cut‑off )
Positive Doubtful Negative Total Positive Doubtful Negative Total
NCS‑MS (A: manufacturer’s cut‑off
B: optimized cut‑off )
Positive 18 1 0 19 26 0 0 26
Doubtful 3 2 0 5 0 0 0 0
Negative 1 3 78 82 3 0 77 80
Total 22 6 78 106 29 0 77 106
Kappa (κ) 0.807 0.926
SE of κ 0.060 0.042
95% CI 0.689–0.925 0.845–1.000
Weighted κ 0.876 0.926
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SAC tested positive for N. caninum. According to the 
SAC species, the estimated seroprevalences in alpacas 
and llamas were 3.5% (13/374) and 2.5% (5/197), respec-
tively, and the seroprevalence at the farm level was 9.1% 
(12/132). Considering the optimized ELISA cut-off, sero-
conversion of the experimentally infected llama could be 
already observed at 19 dpi. (Fig. 3).
The 18 seropositive animals for N. caninum in NCS-
MS ELISA were 13 alpacas and five llamas, 17 animals 
older than 36 months and one animal of unknown age, 
13 females and five males, and derived from 12 different 
farms. In nine of the farms only one animal/ farm (i.e. 
five llamas and four alpacas) tested positive, and in three 
farms 4/5, 3/4 and 2/5 of the tested alpacas were seropos-
itive. The mean ELISA S/P values of the 18 seropositive 
animals was 76.4%. All N. caninum seropositive animals 
were also T. gondii-seropositive.
Neospora caninum immunoblot
Selected field samples (n = 92) and the control animals 
(Llama 1 and 2) were tested by N. caninum immunoblot. 
Based on the results in the NCS-MS ELISA, all samples 
Fig. 3 ELISA results for antibodies against N. caninum on serum samples from a llama experimentally inoculated with 4.8 × 10E6 cell 
culture‑derived N. caninum tachyzoites (Llama 1) and from a control llama inoculated with 5 × 10E4 Vero cells (Llama 2) [30]. a ID Screen® Neospora 
caninum indirect multi‑species, S/P% = sample‑to‑positive ratio, calculated based on the OD (optical density) of the sample and the positive and 
negative controls of the kit according to the formula S/P% =  (ODsample −  ODnegative control/ODpositive control −  ODnegative control) × 100. b ID Screen® 
Neospora caninum Competition, S/N% = competition percentage, calculated according to the formula: S/N% =  (ODsample/ODnegative control) × 100
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with an S/P ≥ 9% (n = 59) and further 33 randomly 
selected samples within the S/P range 1–8.31% were fur-
ther tested by immunoblot. All 14 animals, which were 
classified as positive using the cut-off recommended by 
the manufacturer, as well as the three animals classified 
as inconclusive, tested positive in immunoblot (Fig. 4). A 
further animal with S/P value 34.9% yielded a clear posi-
tive result. An additional sample with S/P value of 14.15% 
in the ELISA also reacted against the immunodominant 
N. caninum antigens. This was a llama from a farm in 
which another N. caninum seropositive animal (by both 
ELISA and immunoblot) had been detected. Besides, also 
two alpacas from a same farm with ELISA S/P values of 
5.39 and 9.99 were positive in the immunoblot.
The llama experimentally inoculated with N. caninum 
tachyzoites (Llama 1), showed reaction against the 29 
kDa immunodominant antigen already at 12 dpi (Fig. 5), 
and against two or more immunodominant N. caninum 
antigens (17, 29, 30, 33 and 37 kDa) from 16 dpi. The N. 
caninum seronegative control animal (Llama 2) did not 
show any reaction against N. caninum antigens through-
out the whole observation period (tested at 2, 19 and 52 
dpi) (Fig. 5).
ID Screen® Neospora caninum Competition ELISA (NCC)
All sera tested by both NCS-MS ELISA and immunoblot 
were subsequently tested by NCC ELISA and the cut-off 
was optimized for SAC based on immunoblot results, as 
indicated above. By ROC analysis, a cut-off of S/N% ≤ 
78.6 was suggested (Table 3). With the optimized cut-off, 
NCC ELISA evidenced a relative sensitivity of 92.9% and 
a relative specificity of 97.4% respect to the N. caninum 
immunoblot, and an almost perfect agreement with 
immunoblot and NCS-MS results (Table  4). With the 
competitive ELISA (considering the optimized cut-off), 
seroconversion in Llama 1 (experimentally inoculated 
with N. caninum tachyzoites) could already be detected 
at 9 dpi, with positive ELISA values until the end of the 
study at 52 dpi. If the cut-offs suggested by the manu-
facturer were considered, seroconversion would have 
occurred 16 dpi, with doubtful values at 12 dpi (Fig 3).
ID Screen® Neospora caninum indirect ELISA (NCS)
All analysed sera, including those from animals posi-
tive in N. caninum immunoblot and serial samples from 
the llama experimentally infected with N. caninum gave 
negative results (ELISA values similar to those from the 
negative controls) in NCS ELISA using an anti-ruminant 
conjugate.
ROC‑analysis and optimization of ELISA cut‑offs for SAC
The relative accuracies of NCS-MS, NCC and TOXO-MS 
ELISAs in relation to N. caninum and T. gondii immuno-
blots, respectively, are provided in Table  3. The statisti-
cal analyses suggested a cut-off of S/P 34.9% for NCS-MS, 
78.6% S/N for NCC, and 36.2% S/P for TOXO-MS ELISA 
(Table  3). The inter-rater agreement (kappa value) 
between all three ELISAs and the respective immunob-
lots and between NCS-MS and NCC ELISA are provided 
in Table 4. The agreement of all three tested ELISAs with 
immunoblot was almost perfect, being higher when the 
adapted cut-offs were considered. Further, also the agree-
ment between both N. caninum ELISAs (NCS-MS and 
NCC) was almost perfect (Table 4).
Fig. 4 Immunoblot results for antibodies against N. caninum on field serum samples from Swiss South American camelids (SAC). Abbreviations: M, 
marker; PB, positive control (bovine); PC, positive control (Llama 1); NC, negative control (Llama 2); samples 8–28, Swiss SAC field serum samples; +, 
positive immunoblot result; −, negative immunoblot result. Bands corresponding to immunodominant N. caninum antigens (17, 29, 30, 33 and 37 
kDa) are indicated with *. Samples recognizing two or more immunodominant antigens were considered positive
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Questionnaire and risk factor analysis
A total of 41 out of 132 (31.1%) farms responded to the 
web-based questionnaire. These farms accounted for 
189 out of the 571 (33%) animals sampled in the survey. 
Twenty-two farms bred exclusively alpacas, 12 farms 
exclusively llamas and seven farms bred both species. 
Considering only the responding farms and the adapted 
ELISA cut-offs, the seroprevalences for T. gondii and N. 
caninum at the farm level were 100% (n = 41/41) and 
14.6% (n = 6/41), respectively, and at the animal level 
77.8% (n = 147/189) and 5.8% (n = 11/189), respectively. 
Regarding the SAC species, 75.8% (91/120) of the alpacas 
and 81.2% (56/69) of the llamas were seropositive for T. 
gondii and 6.7% (8/120) of the alpacas and 4.3% (3/69) of 
the llamas were seropositive for N. caninum.
All 41 responding farms bred Swiss SAC (born at the 
same farm or purchased from other Swiss farms). Only 
five farms (12.2%) had purchased few animals abroad (i.e. 
Peru, Chile, USA, Australia, New Zealand and Germany). 
None of the tested animals from those five farms evi-
denced antibodies against N. caninum.
Thirty-five (85.4%) of the farms reported presence of 
cats (one cat up to >10 cats) in the last two years, and 
kittens had been present in eight of these farms (22.9%). 
Either own or foreign/neighbouring cats had access to 
the pasture and stable in 34 (97.1%) and 33 (94.3%) of 
these farms, respectively. Own dogs (up to four dogs) 
were present in 22/41 (56.7%) of the farms during the 
last two years and two (9.1%) of those farms had pup-
pies. Own dogs had access to the stable and pasture in 
21 (95.4%) of those 22 farms and foreign/neighbouring 
dogs were seen in at least 11 farms. Seven (17%) of the 
farms had problems with rodents, and 34/41 (82.9%) of 
the farms reported breeding other animal species (i.e. 
cattle, sheep, goats, equids, pigs, poultry, rabbits, quails, 
and fallow deer) besides SAC. Eleven (26.8%) of the par-
ticipating farms experienced abortions (up to five abor-
tions) during the last two years and only one of the farms 
submitted the aborted foetuses for investigation, but no 
abortion cause could be detected.
Since all responding farms were T. gondii-seropositive 
(i.e. all 41 farms had at least one seropositive animal), no 
risk analysis for T. gondii at the farm level was possible. By 
generalized linear mixed modelling considering the indi-
vidual serological status, the variable “age” (in months) 
was identified as putative risk factor for infection with 
T. gondii (Table 5) and female animals had a significantly 
increased risk of being T. gondii-seropositive (Table  5). 
Fig. 5 Immunoblot results for antibodies against N. caninum on serum samples from a llama experimentally inoculated with 4.8 × 10E6 cell 
culture‑derived N. caninum tachyzoites (Llama 1) and from a seronegative control llama inoculated with 5 × 10E4 Vero cells (Llama 2). Abbreviations: 
M, marker; kDa, kilodaltons; 2–52 (indicated above), days post‑inoculation (dpi). Bands corresponding to immunodominant N. caninum antigens (17, 
29, 30, 33 and 37 kDa) are indicated with an asterisk. In Llama 1, reaction against the 29 kDa antigen is observed at 12 dpi. From 16 to 52 dpi also 
further immunodominant antigens are recognized. Samples recognizing two or more immunodominant antigens were considered positive. Llama 
2 did not recognize any of the N. caninum immunodominant antigens during the observation period
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The variable “absence of cats in the farm during the last 
two years” was identified as a protective factor (Table 5).
None of the examined variables could be classified 
as a risk factor for N. caninum seropositivity, as the 
observed differences were not statistically significant. 
Moreover, modelling considering the infection status 
of the individual animals was not possible, because only 
11 animals of six out of 41 farms that had answered the 
questionnaire tested positive, with four of these farms 
in which only a single animal tested positive. The rela-
tion of the putative risk factors with seropositivity to 
N. caninum at the farm level is displayed in Additional 
file 1: Table S1.
Discussion
The multi-species T. gondii and N. caninum ELISA kits 
used in this study (i.e. TOXO-MS and NCS-MS) were 
not previously validated for their use on SAC; there-
fore, the results obtained on SAC field samples were 
further confirmed by immunoblot, and control sera 
with known positive or negative serological status for 
T. gondii and N. caninum infections were included in 
the analyses. The immunoblot method was chosen as 
“gold standard for comparison” to estimate the cut-off 
of the kits for testing SAC and their relative diagnostic 
characteristics considering the optimized cut-offs. Sub-
sequently, two further ELISA kits for detection of anti-
bodies against N. caninum (i.e. NCC and NCS) were 
additionally evaluated on samples with known immu-
noblot results. With the optimized cut-offs, TOXO-MS, 
NCS-MS and NCC ELISAs had almost perfect agree-
ment with immunoblot results (Table 4). Moreover, an 
almost perfect agreement was also observed between 
NCS-MS and NCC ELISAs (Table  4). On the other 
hand, a new version of the indirect ELISA (NCS), which 
uses an anti-ruminant conjugate, proved not to be suit-
able for testing SAC because it did not detect animals 
which tested seropositive for N. caninum antibodies 
both by immunoblot and by the two further tested N. 
caninum ELISAs. This kit differs from NCS-MS only in 
the used conjugate.
Almost nothing is known about the epidemiologi-
cal situation or the clinical significance of T. gondii and 
N. caninum infections in SAC in Europe. Differences in 
the type of husbandry, possibility of contact with defini-
tive hosts, geographical factors and/or occurrence of 
co-infections with other agents might influence the 
occurrence and/or clinical significance of these proto-
zoan infections in Europe. Regarding prevalence stud-
ies on T. gondii infection, only few countries (i.e. Chile, 
Argentina, USA, Germany and Czech Republic) besides 
Peru (where several regional surveys have been carried 
out (Table  1)), investigated the occurrence of T. gondii 
antibodies in SAC. In Peru seroprevalences between 3.0 
and 44.5% in alpacas, 8.6 and 44.2% in llamas and 2.6 and 
5.5% in vicunas were reported (Table 1). In Argentina, a 
seroprevalence of 14.3% was reported in llamas from the 
North Western region by IFAT [37], and in Chile, preva-
lences of 7.2–11.8% in alpacas [38, 39] and 43.3% in lla-
mas [39] were observed. In the USA, seroprevalences of 
37.5 and 33.5% by MAT were observed in 16 alpacas [40] 
and 283 llamas [41], respectively. In Europe, antibodies 
against T. gondii were previously detected in a few SAC 
in Germany [30] and Czech Republic [42] by immunob-
lot, ELISA and/or IFAT. In this study, a general seroprev-
alence of 83.2% (475/571) in SAC living in Switzerland 
was revealed, which corresponded to seroprevalences of 
Table 5 Fixed effects in generalized linear mixed models 
to determine potential risk factors for Toxoplasma gondii‑
seropositivity in Swiss South American camelids
Notes: Data were analysed by bivariable generalized linear mixed modelling 
including “Age” (months) as effect modifier and “Farm” as random effects variable 
in modelling T. gondii-seropositivity. The Akaike information criterion (AIC) was 
used to characterize the relative model quality
Abbreviation: ref., reference
*P ≤ 0.05, **P ≤ 0.01, ***P < 0.001
Model 
(AIC, 
model fit)
Variable Odds ratio (95% 
CI)
z-value P‑value
1 (155.9) Intercept 1.090 (0.390–
3.070)
0.170 0.864644
Age (months) 1.020 (1.010–
1.040)
3.602 0.000316***
2 (153.4) Intercept 0.607 (0.209–
1.760)
− 0.919 0.358139
Age 1.021 (1.009–
1.030)
3.497 0.000471***
Sex: male (ref.)
Sex: female 2.924 (1.111–
7.690)
2.174 0.029711*
3 (152.4) Intercept 1.228 (0.460–
3.278)
0.410 0.681820
Age 1.024 (1.011–
1.036)
3.707 0.000210***
Cat, past 2 years 
(ref.)
No cat, past 2 
years
0.214 (0.055–
0.828)
− 2.233 0.025530*
4 (149.3) Intercept 0.692 (0.255–
1.880)
− 0.722 0.470200
Age 1.021 (1.009–
1.033)
3.540 0.000400***
Sex: male (ref.)
Sex: female 2.941 (1.164–
7.426)
2.282 0.022500*
Cat, past 2 years 
(ref.)
No cat, past 2 
years
0.232 (0.066–
0.809)
− 2.293 0.021900*
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82.3% (308/374) and 84.8% (167/197) in alpacas and lla-
mas, respectively.
Seropositive animals derived from 131 out of 132 
(99.2%) sampled farms. Although due to differences in 
the serological techniques and cut-offs used in the differ-
ent surveys, a direct comparison of some studies is not 
always possible, the here observed prevalences are much 
higher than those reported worldwide so far (Table  1). 
This is in agreement with the high (i.e. 80.7%) T. gondii 
seroprevalence observed in Swiss ewes by P30-ELISA 
on meat juice [43]. The higher seroprevalence in SAC 
in Switzerland may be related to a more intensive man-
agement than in other geographical regions, enabling 
a closer contact with human premises and with domes-
tic cats, which contaminate the pastures with their fae-
ces. South American camelids often share grazing lands 
with sheep, being exposed to the same infection sources. 
Reported frequencies of domestic cats shedding T. gon-
dii oocysts in Switzerland were between 0.4 [44] and 
0.6% [45], which is probably > 10 times higher to that of 
dogs shedding N. caninum oocysts. Moreover, the num-
ber of owned cats living in Switzerland is approximately 
three times higher than that of owned dogs (in year 2018: 
1,634,000 cats vs 506,000 dogs) [46], what can account 
for a higher environmental contamination with T. gondii 
oocysts.
Knowledge on the risk factors for infection is essential 
to make decisions on possible intervention measures. 
In ruminants, the main routes of infection with T. gon-
dii include the ingestion of oocysts contaminating feed, 
water or the environment, and secondary, transplacental 
transmission [47]. In our study, the variables “age” and 
“female sex” were identified by multivariable statistical 
analysis as putative risk factors for T. gondii infection, 
while “absence of cats in the farm during the last two 
years” was suggested as a protective factor. The variable 
age was identified as a risk factor for T. gondii infection 
in numerous studies on different livestock species includ-
ing small ruminants, cattle, equids, pigs and chicken [47]. 
In studies on SAC from Peru [30, 48–50], Chile [39] and 
Germany [30], it was observed that the seroprevalence 
of T. gondii infection increased with age, suggesting that 
most infections would occur postnatally. Accordingly, 
also in this study the variable age was estimated as a puta-
tive risk factor for infection (here also referred to as effect 
modifying variable in statistical analysis), and this can 
be explained, as older animals had more often the pos-
sibility of being exposed to T. gondii oocysts after birth 
than younger ones. While the variable “female sex” was 
suggested as putative risk factor for T. gondii seropositiv-
ity in few studies on small ruminants, pigs and equids; in 
most of the reported studies on livestock there was no 
statistical differences in the seroprevalence between both 
sexes [47]. It has to be considered that this apparent asso-
ciation might mask underlying factors such as differences 
in the way both sexes are reared more than to specific 
differences in susceptibility [47]. While in two studies 
from Peru, no statistical differences were observed in the 
seroprevalence of T. gondii infection between female and 
male alpacas [49, 50], in a further study it was found that 
female sex was a risk factor for acquiring toxoplasmosis 
in alpacas, but not in llamas [48]. The authors hypoth-
esized that this could be due to differences in manage-
ment, as llamas and male alpacas were pastured in cold, 
dry regions above 4000 m above sea level, and female 
alpacas were kept in lower, wet areas, what could account 
for a longer survival of T. gondii oocysts. Also in our 
study, female sex seemed to be a risk factor for T. gondii 
infection. In Switzerland, males are often held in “male 
herds”, separated from the females; however, there are no 
big differences in the general management of both sexes 
that could account for a higher exposure to the parasite 
in females. While different experimental studies sug-
gested a higher susceptibility of female mice and guinea 
pigs to infection with T. gondii [47], it is not known if this 
also applies to SAC.
Further, the variable “absence of cats in the farm dur-
ing the last two years” was identified as a “protective fac-
tor” for T. gondii infection. Cats, as definitive hosts of T. 
gondii, are responsible for environmental contamination 
with oocysts shed with their faeces, which may survive 
for several months (usually < 2 years) in the environ-
ment, and sporulated oocysts represent the main source 
of infection for ruminants [47]. Therefore, reporting an 
absence of cats on farms would account for lower chances 
of contamination of farmland, feed or water with oocysts.
The potential role of T. gondii-infected SAC meat as a 
source of infection for humans has been barely investi-
gated and more studies are needed to better understand 
the correlation between seropositivity and presence 
of viable parasites in the tissues as well as to define the 
predilection sites of T. gondii in SAC. Recently, T. gon-
dii was isolated from heart or muscle tissues from two 
out of six seropositive alpacas by bioassay in mice in the 
USA [40]. Meat from SAC represents an important food 
source for the Andean population in South America, 
where it is consumed as different local dishes not only 
cooked (e.g. as chupe, locro, pachamanca) but also raw in 
different preparations (e.g. as charqui, sausages or cevi-
che) [51]. In recent years, due to the higher protein and 
lower fat and cholesterol contents compared with meat 
from other livestock species, SAC meat has become an 
interesting kind of alternative red meat both for the local 
and international kitchen [52]. In Switzerland there are at 
least 15 listed providers of SAC meat and meat products 
[23]. SAC meat represents a gourmet dish, and it is often 
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cooked only shortly at low temperature and consumed 
undercooked or raw as dried meat or sausages [23]. Given 
the high T. gondii seroprevalence observed, SAC meat 
might represent a potential infection source for humans 
if no treatment for parasite inactivation (e.g. cooking 
with core temperature > 67 °C, freezing at < − 12 °C for 
>2 days) [1] is carried out.
Surveys based on the presence of N. caninum antibod-
ies in blood sera from SAC have been scarcely performed 
worldwide and data from only few countries (i.e. Peru, 
Argentina, Australia, Germany and Czech Republic) are 
available (Table 2). Most of the studies were performed in 
Peru, mainly in the Andes region, and revealed seroprev-
alences of 0.3–42.4% in alpacas, 0–23.3% in llamas and 
0–1% in vicunas (Vicugna vicugna) by various serological 
tests (Table 2). In Argentina, a study on 308 llamas from 
the North-Western region revealed a seroprevalence 
of 1% by IFAT [7]. Outside South America, only studies 
involving few animals were performed and the observed 
seroprevalences were low (≤ 3%) [24, 30, 53]. In Europe, 
only two small serological studies have been published to 
date [30, 42]. Neospora caninum infection could not be 
serologically detected in any of 32 SAC by immunoblot in 
Germany [30], and it was diagnosed in one out of 9 SAC 
in the Czech Republic by ELISA and IFAT [42]. Accord-
ingly, also in the present study low seroprevalences of 
N. caninum infection were observed. While most sero-
surveys for N. caninum and T. gondii infections were 
performed at local or regional levels, this study aimed 
to reveal the epidemiological situation of these proto-
zoan infections at a nationwide level. Antibodies against 
N. caninum were detected by ELISA and confirmed 
by immunoblot in 3.15% (18/571) of the tested animals 
and in 9.1% (12/132) of the farms (Fig.  1). Considering 
the SAC species, 3.5% (13/374) of the alpacas and 2.5% 
(5/197) of the llamas tested in Switzerland were seroposi-
tive. Seropositive animals derived from 12 farms localized 
in seven Swiss cantons, showing a nationwide distribu-
tion of the parasite (Fig. 1). At least 12 out of the 18 sero-
positive animals derived from farms (n = 6) that reported 
not having imported animals. This suggests that the ani-
mals may get infected (horizontally or vertically) in Swit-
zerland. For the remaining six animals, no information 
about a possible imported origin was known. In cattle, 
vertical transmission was considered the most important 
route of N. caninum infection, and it was shown that the 
parasite can persist in the herd during several generations 
even without further participation of the definitive host 
[54]. However, nothing is known about the efficiency of 
vertical transmission of N. caninum in SAC or about the 
meaning of horizontal transmission through the inges-
tion of sporulated oocysts shed by canids in these ani-
mal species. In Peru, no significant association was found 
between seropositivity to N. caninum in SAC and age [55, 
56] or geographical region [57], suggesting that the infec-
tion might be mainly transmitted vertically [57]. Apart 
from some regional studies from Peru, in which higher 
seroprevalences of infection were reported (17.9–42.4 % 
in alpacas and 18.4–23.3% in llamas) [58, 59], only low 
seroprevalences were observed in studies outside South 
America, suggesting that only few animals had contact 
with the parasite. In Europe, N. caninum oocysts were 
detected in the faeces of only few dogs [60–64], with 
prevalences < 0.05% [63], suggesting that the environ-
mental contamination with oocysts might be low. Nev-
ertheless, acute infections with N. caninum oocysts were 
considered responsible for epidemic abortion outbreaks 
in several cattle farms in the region, showing that under 
certain epidemiological situations focal contamination 
with N. caninum oocysts may occur [65, 66].
It is believed that T. gondii and N. caninum infections 
in SAC are generally subclinical, and accordingly, sero-
logically positive animals in this study did not show any 
clinical signs. However, in recent years a case of gener-
alized fatal toxoplasmosis was described in a 13-month-
old llama in the USA. Due to the character of the lesions, 
which included gastritis and enteritis, it was assumed 
that the animal became infected through ingestion of 
oocysts contaminating feed or water [21]. Therefore, also 
potential clinical aspects of this infection should be con-
sidered. Besides, T. gondii and N. caninum infections are 
known causes of reproductive failure (i.e. abortion, still-
births and perinatal mortality) in different domestic and 
wild ruminant species [9, 10, 13, 14, 17, 65] but only few 
studies were performed to elucidate their significance 
in SAC. In Peru, N. caninum DNA and associated his-
tological lesions were detected in the brain from three 
out of 15 aborted SAC foetuses (i.e. 2/6 alpaca and 1/9 
llama foetuses) from the Puno region [19]. Additionally, 
N. caninum infection was also detected by PCR or immu-
nohistochemistry in further 14/50 aborted SAC foetuses 
(i.e. 10/32 alpacas and 4/18 llamas) from the Central 
and South Andean regions of the Peruvian Highlands, of 
which eight foetuses also showed compatible lesions [18]. 
On the other hand, the role of T. gondii as cause of abor-
tion in SAC has been subject of debate [57]. Two naïve 
llamas infected either experimentally or naturally with T. 
gondii during pregnancy remained clinically normal and 
delivered healthy, seronegative crias, suggesting that no 
transplacental transmission of the parasite occurred [67]. 
Later, T. gondii DNA was not detected in any of 15 [19] 
or 50 aborted foetuses from alpacas and llamas from Peru 
(while N. caninum was detected in some of the abor-
tions), providing presumptive evidence that T. gondii 
is less important as a cause of abortion in SAC than N. 
caninum [18]. However, in the USA, toxoplasmosis was 
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implicated as a cause of abortion in llamas, and antibod-
ies against T. gondii were detected in foetal fluids from 
aborted foetuses [68]. Moreover, in recent years, T. gon-
dii was confirmed as the cause of abortion in a near full-
term alpaca foetus [20]. Nevertheless, the real prevalence 
of N. caninum and T. gondii associated abortions in SAC 
might be often underestimated, as aborted foetuses from 
these animal species seem to be only rarely submitted to 
the laboratory for further diagnosis [24]. In our study, 
only one out of 11 farms which experienced abortions in 
SAC reported having sent abortion material for etiologi-
cal investigation. Further studies to estimate the involve-
ment of these parasites as cause of abortion in SAC in 
Switzerland are on-going.
Conclusions
One commercial ELISA kit for detection of antibodies 
against T. gondii and two kits for detection of N. caninum 
antibodies were assessed for their use in SAC and their 
cut-offs were optimized, showing almost perfect agree-
ment with immunoblot results. One further commercial 
kit for the detection of antibodies against N. caninum in 
ruminants proved not to be useful for testing SAC. This 
nationwide cross-sectional study demonstrates, to our 
knowledge for the first time, the presence of antibod-
ies against T. gondii and N. caninum in the Swiss SAC 
population and shed some light on the current epide-
miological situation of these parasites, highlighting the 
occurrence of a low seroprevalence of N. caninum infec-
tion and a very high seroprevalence of T. gondii infection 
in llamas and alpacas in Switzerland, suggesting that SAC 
meat might represent an additional infection source for 
humans.
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